The Expression and Environmental Regulation of P450 Enzymes in Human Placenta

References

• Mihaly G. W., Morgan D. J. Placental drug transfer: effects of gestational age and species. Pharmacol. Ther. 1984; 23: 253
   Web of Science ®Google Scholar
• Pelkonen O. Fetoplacental biochemistry — xenobiotic metabolism and pharmacokinetics. Occupational Hazards and Reproduction, Sorsa Hemminki, Vainio. Hemisphere, Washington, D.C. 1985
   Google Scholar
• Gonzalez F. J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 1989; 40: 243
   Web of Science ®Google Scholar
• Schenkman J. B. Steroid metabolism by constitutive cytochrome-P450. J. Steroid Biochem. Mol. Biol. 1992; 43: 1023
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Characterization of human cytochrome P450 enzymes. FASEB, J. 1992; 6: 745
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Characterization of human microsomal cytochrome P-450 enzymes. Annu. Rev. Pharmacol. Toxicol. 1989; 29: 241
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J. Human cytochromes P450: problems and prospects. RIPS 1992; 13: 346
   Google Scholar
• Pelkonen O., Nebert D. W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 1982; 34: 189
   PubMed Web of Science ®Google Scholar
• Pasanen M., Pelkonen O. Xenobiotic and steroid-metabolizing monooxygenases catalyzed by cytochrome P450 and glutathione 5-transferase conjugations in the human placenta and their relationships to maternal cigarette smoking. Placenta 1990; 11: 75
   PubMed Web of Science ®Google Scholar
• Honkakoski P., Kojo A., Raunio H., Pasanen M., Juvonen R., Lang M. A. Hepatic mitochondrial coumarin 7-hydroxylase: immunochemical and catalytic comparison with the microsomal enzyme. Arch. Biochem. Biophys. 1989; 267: 558
   Google Scholar
• Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P.W. E. R., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsaius I. C., Gotoh O., Okuda K., Nebert D. W. The P450 super-family: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993; 12: 1
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Nelson D. R., Coon M. R., Estabrook R. W., Feyereisen R., Fujii-Kuriyama Y., Gonzalez F. J., Guengerich F. P., Gunsaius I. C., Johnson E. F., Loper J. C., Sato R., Waterman M. R., Waxman D. J. The P450 superfamily: update on new sequences, gene mapping and recommended nomenclature. DNA Cell Biol. 1991; 10: 1
   PubMed Web of Science ®Google Scholar
• Langenbach R., Smith P. B., Crespi C. Recombinant DNA approaches for the development of metabolic systems used inin vitro toxicology. Mutat. Res. 1992; 277: 251
   PubMed Web of Science ®Google Scholar
• Juchau M. R. Drug biotransformation in the placenta. Pharmacol. Ther. 1980; 8: 501
   PubMed Web of Science ®Google Scholar
• Pasanen M., Pelkonen O. Human placental xenobiotic and steroid biotransformations catalyzed by cytochrome P450, epoxide hydrolase, and glutathione 5-transferase activities and their relationships to maternal cigarette smoking. Drug Metab. Rev. 1989; 21: 427
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Vähäkangas K., Kärki N. T., Sotaniemi E. A. Genetic and environmental regulation of aryl hydrocarbon hydroxylase in man: studies with liver, lung, placenta and lymphocytes. Toxicol. Pathol. 1984; 12: 256
   PubMedGoogle Scholar
• Kaelin A. C., Cummings A. J. Differential inhibition of human placental monooxygenase activity: evidence for multiple forms of 7-ethoxycoumarinO-deethylase. Biochem. Pharmacol. 1984; 33: 505
   PubMed Web of Science ®Google Scholar
• Juchau M. R. Human placental hydroxylation of 3,4-benzo(a)pyrene during early gestation and at term. Toxicol. Appl. Pharmacol. 1971; 18: 665
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Arvela P., Kärki N. T. 3,4-Benzpyrene andN-methylalanine metabolizing enzymes in the immature human foetus and placenta. Acta Pharmacol. Toxicol. 1971; 30: 385
   PubMedGoogle Scholar
• Pelkonen O., Jouppila P., Kärki N. T. Effect of maternal cigarette smoking in 3,4-benzpyrene andN-methylaniline metabolism in human fetal liver and placenta. Toxicol. Appl. Pharmacol. 1972; 23: 399
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Jouppila P., Kärki N. T. Attempts to induce drug metabolism in human fetal liver and placenta by the administration of phenobarbital to mothers. Arch. Int. Pharmacodyn. Ther. 1973; 202: 288
   PubMedGoogle Scholar
• Juchau M. R., Zachariah P. K. Comparative studies on the oxidation and reduction of drug substrates in human versus rat hepatic microsomes. Biochem. Pharmacol. 1975; 24: 277
   PubMedGoogle Scholar
• Pelkonen O., Pasanen M., Kuha H. B. G., Kairaluoma M., Sotaniemi E. A., Park S. S., Friedman F. K., Gelboin H. V. The effect of cigarette smoking on 7-ethoxyresorufinO-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies. Br. J. Clin. Pharmacol. 1986; 22: 125
   PubMed Web of Science ®Google Scholar
• Gurtoo H. L., Williams C. J., Gottlieb K., Mulhern A. I., Caballes L., Vaught J. B., Marinello A. J. Population distribution of placental benzo(a)pyrene metabolism in smokers. Int. J. Cancer 1983; 31: 29
   PubMed Web of Science ®Google Scholar
• Pasanen M., Vähäkangas K., Sotaniemi E. A., Pelkonen O. The effect of cigarette smoking on drug metabolism in the liver and placenta: the use of cotinine in verifying smoking status. Eur. J. Drug Metab. Pharmacokinet. 1988; 13: 41
   PubMed Web of Science ®Google Scholar
• Boadi W. A., Urbach J., Barnea E. R., Brandes J. M., Yannai S. Enzyme activities in the term human placenta:in vitro effect of cadmium. Pharmacol. Toxicol. 1992; 71: 209
   PubMedGoogle Scholar
• Vähäkangas K., Pelkonen O., Sotaniemi E. Cigarette smoking and drug metabolism. Clin. Pharmacol. Ther. 1983; 33: 375
   PubMed Web of Science ®Google Scholar
• Petruzzelli S., Camus A.-M., Carrozzi L., Ghelarducci L., Rindi M., Menconi G., Angeletti C. A., Ahotupa M., Hietanen E., Aitio A., Saracci R., Bartsch H., Giuntini C. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients. Cancer Res. 1988; 48: 4695
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Kärki N. T., Korhonen P., Koivisto M., Tuimala R., Kauppila A. Human placental aryl hydrocarbon hydroxylase: genetics and environmental influences. Polynuclear Aromatic Hydrocarbons, Jones, Leber. Ann Arbor Science, Ann Arbor, MI 1979; 765
   Google Scholar
• Jacobson M., Levin W., Poppers P., Wood A. W., Conney A. H. Comparison of theO-Dealkylation of 7-ethoxycoumarin and the hydroxylation of benzo(a)pyrene in human placenta. Clin. Pharmacol. Ther. 1974; 16: 701
   PubMed Web of Science ®Google Scholar
• Kaelin A. C., Cummings A. J. A survey of aryl hydrocarbon hydroxylase activity in human placental homogenates. Placenta 1983; 4: 471
   PubMed Web of Science ®Google Scholar
• Pasanen M., Taskinen T., Iscan M., Sotaniemi E. A., Kairaluoma M. A., Pelkonen O. Inhibition of human hepatic and placental xenobiotic monooxygenases by imidazole antimycotics. Biochem. Pharmacol. 1988; 37: 3861
   PubMed Web of Science ®Google Scholar
• Manchester D., Jacogy E. Sensitivity of human placental monooxygenase activity to maternal smoking. Clin. Pharmacol. Ther. 1981; 30: 687
   PubMed Web of Science ®Google Scholar
• Rettie A. F., Heimark L., Mayer R. T., Burke M. D., Trager W. F., Jucahu M. R. Stereoselective and regioselective hydroxylation of warfarin and selectiveO-dealkylation of phenoxazone ethers in human placenta. Biochem. Biophys. Res. Commun. 1985; 126: 1013
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Moilanen M.-L. The specificity and multiplicity of human placental xenobiotic-metabolizing monooxygenase system studied by potential substrates, inhibitors and gel electrophoresis. Med. Biol. 1979; 57: 306
   PubMedGoogle Scholar
• Pasanen M., Pelkonen O., Kauppila A., Park S. S., Friedman F. K., Gelboin H. V. Characterization of human fetal hepatic cytochrome P-450-associated 7-ethoxyresorufinO-deethylase and aryl hydrocarbon hydroxylase activities by monoclonal antibodies. Dev. Pharmacol. Ther. 1987; 10: 125
   PubMedGoogle Scholar
• Pasanen M., Taskinen T., Sotaniemi E. A., Kairaluoma M., Pelkonen O. Inhibitor panel studies of human hepatic and placental cytochrome P-450-associated monooxygenase activities. Pharmacol. Toxicol 1988; 62: 311
   PubMedGoogle Scholar
• Fujino T., Park S. S., West D., Gelboin H. V. Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 1982; 79: 3682
   PubMed Web of Science ®Google Scholar
• Fujino T., Gottlieb K., Manchester D. K., Park S. S., West D., Gurtoo H. L., Tarone R. E., Gelboin H. V. Monoclonal antibody phenotyping of interindividual differences in cytochrome P-450-dependent reactions of single and twin human placenta. Cancer Res. 1984; 44: 3916
   PubMed Web of Science ®Google Scholar
• Hakkola J., Mäenpää J., Mayer R. T., Park S. S., Gelboin H. V., Pelkonen O. 7-AlkoxyquinolineO-dealkylation by microsomes from human liver and placenta. Br. J. Clin. Pharmacol. 1992; 34: 415
   PubMed Web of Science ®Google Scholar
• Pasanen M., Haaparanta T., Sundin M., Sivonen P., Vähäkangas K., Raunio H., Hines R., Gustafsson J.-Å., Pelkonen O. Immunochemical and molecular biochemical studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities. Toxicology 1990; 62: 175
   PubMed Web of Science ®Google Scholar
• Vähäkangas K., Raunio H., Pasanen M., Sivonen P., Park S. S., Gelboin H. V., Pelkonen O. Comparison of the formation of benzo(a)pyrene diolepoxide-DNA adducts in vitro by rat and human microsomes: evidence for the involvement of P-450IA1 and P-450IA2. J. Biochem. Toxicol. 1989; 4: 79
   PubMedGoogle Scholar
• Pasanen M., Stenbäck F., Park S. S., Gelboin H. V., Pelkonen O. Immunohistochemical detection of human placental cytochrome P-450-associated monooxygenase system induced by maternal cigarette smoking. Placenta 1988; 9: 267
   PubMed Web of Science ®Google Scholar
• Wong T. K., Everson R. B., Hsu S.-T. Potent induction of human placental monooxygenase activity by previous dietary exposure to polychlorinated biphenyls and their thermal degradation products. Lancet 1985; i: 721
   Google Scholar
• Pasanen M., Pelkonen O. Inhibition of xenobiotic and steroid metabolism by amino-glutethimide in human placentas from smoking and non-smoking mothers. Extrahepatic Drug Metabolism and Chemical Carcinogenesis, Rydstrom, Montelius, Bengtsson. Elsevier/North-Holland, Amsterdam 1983
   Google Scholar
• Berry D. L., Zachariah P. K., Slaga T. J., Juchau M. R. Analysis of the biotransformation of benzo(a)pyrene in human fetal and placental tissues with high-pressure liquid chromatography. Eur. J. Cancer 1977; 13: 667
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Lapenson D. P., Aoyama T., Gelboin H. V., Gonzalez F. J., Korzekwa K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch. Biochem. Biophys. 1991; 290: 160
   PubMed Web of Science ®Google Scholar
• Omar H. A., Figueroa R., Omar R. A., Wolin M. S. Properties of an endogenous arachidonic acid-elicited relaxing mechanism in human placental vessels. Am. J. Obstet. Gynecol. 1992; 167: 1064
   PubMedGoogle Scholar
• Meigs R. A. The constitutive 7-ethoxycoumarinO-deethylase activity of human placental microsomes: relationship to aromatase. Biochem. Biophys. Res. Commun. 1987; 134: 1012
   Google Scholar
• Sesardic D., Pasanen M., Pelkonen O., Boobis A. R. Differential expression and regulation of numbers of the cytochrome P450IA gene subfamily in human tissues. Carcinogenesis 1990; 11: 1183
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Rettie A. E. Drug and Chemical Action in Pregnancy: Pharmacologic and Toxicologic Principles, Fabrio, Scialli. Marcel Dekker, New York 1986
   Google Scholar
• Wrighton S. A., Stevens J. C. The human hepatic cytochromes P450 involves in drug metabolism. Crit. Rev. Toxicol. 1992; 22: 1
   PubMed Web of Science ®Google Scholar
• Alvan G., Bechtel P., Iselius L., Gundert-Remy U. The hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations. Eur. J. Clin. Pharmacol. 1990; 39: 533
   PubMed Web of Science ®Google Scholar
• Song B. J., Matsunaga T., Hardwick J. P., Park S. S., Veech R. L., Yang C. S., Gelboin H. V., Gonzalez F. J. Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol. Endocrinol. 1987; 1: 542
   PubMed Web of Science ®Google Scholar
• Song B. J., Veech R. L., Saenger P. Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. Clin. Endocrinol. Metab. 1990; 71: 1036
   Google Scholar
• Jones S. M., Boobis A. R., Moore G. E., Stanier P. M. Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples. Biochem. Pharmacol. 1992; 43: 1876
   PubMed Web of Science ®Google Scholar
• Sheean L. A. Aromatization of androstenedione by microsomes from the human placenta after gestational alcohol consumption. Alcohol. Clin. Exp. Res. 1983; 7: 93
   PubMedGoogle Scholar
• Murray M. P450-enzymes — inhibition mechanisms, genetic regulation and effects of liver disease. Clin. Pharmacokinet. 1992; 23: 132
   PubMed Web of Science ®Google Scholar
• Yun C. H. Y., Shimada T., Guengerich P. F. Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene. Cancer Res. 1992; 52: 1868
   PubMed Web of Science ®Google Scholar
• Bornheim L. M., Correia M. A. Selective inactivation of mouse liver cytochrome P450IIA by cannabidiol. Mol Pharmacol. 1990; 38: 319
   PubMed Web of Science ®Google Scholar
• Kitada M., Kamataki T., Itahashi K., Rikihisa T., Kanakubo Y. Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidation. Biochem. Pharmacol. 1987; 36: 453
   PubMed Web of Science ®Google Scholar
• Mäenpää J., Pelkonen O., Cresteil T., Rane A. The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. J. Steroid Biochem. Mol. Biol. 1993; 44: 61
   PubMed Web of Science ®Google Scholar
• Mäenpää J., Rane A., Raunio H., Honkakoski P., Pelkonen O. Cytochrome P450 isoforms in human fetal tissues related to phenobarbital-inducible forms in the mouse. Biochem. Pharmacol. 1993; 45: 899
   PubMed Web of Science ®Google Scholar
• Schuetz J. D., Kauma S., Guzelian P. S. Identification of the fetal liver cytochrome-CYP3A7 in human endometrium and placenta. J. Clin. Invest. 1993; 92: 1018
   PubMed Web of Science ®Google Scholar
• Simmons D. L., Kasper C. B. Quantitation of mRNAs specific for the mixed-function oxidase system in rat liver and extrahepatic tissues during development. Arch. Biochem. Biophys. 1989; 271: 10
   PubMed Web of Science ®Google Scholar
• Wong T. K., Domin B. A., Bent P. E., Blanton T. E., Anderson M. W., Philpot R. M. Correlation of placental microsomal activities with protein detected by antibodies to rabbit cytochrome P-450 isozyme 6 in preparation from humans exposed to polychlorinated biphenyls, quaterphenyls, and dibenzofurans. Cancer Res. 1986; 46: 999
   PubMed Web of Science ®Google Scholar
• Hincal F. Effects of exposure to air pollution and smoking on the placental aryl hydrocarbon hydroxylase (AHH) activity. Arch. Environ. Health 1986; 41: 377
   PubMed Web of Science ®Google Scholar
• Khan S., Martin M., Rahimtula A. D., Payne J. F. Effect of Prudhoe Bay crude oil on hepatic and placental drug metabolism in rats. Can. J. Physiol. Pharmacol. 1987; 65: 2400
   PubMed Web of Science ®Google Scholar
• Pelkonen O. Differential inhibition of aryl hydrocarbon hydroxylase in human foetal liver, adrenal gland and placenta. Acta Pharmacol. Toxicol. 1977; 41: 306
   PubMedGoogle Scholar
• Nebert D. W. TheAh locus: genetic differences in toxicity, cancer, mutation, and bird defects. Crit. Rev. Toxicol. 1989; 20: 137
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Zachariah P. K. Displacement of carbon monooxide from placental cytochrome P450 by steroids: antagonistic effects of androstenedione and 19-norandrostenedione. Biochem. Biophys. Res. Commun. 1975; 65: 1026
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Symms K. G. Aniline hydroxylation in human placenta — mechanistic aspects. Biochem. Pharmacol. 1972; 21: 2053
   PubMed Web of Science ®Google Scholar
• Bergheim P., Rathgen G. H., Netter K. J. Interaction of drugs and steroids with human placental microsomes. Biochem. Pharmacol. 1973; 22: 1633
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Namkung M. J. Studies on the biotransformation on naphthalene-1,2-oxide in fetal and placental tissues of humans and monkeys. Drug Metab. Dispos. Biol. Fate Chem. 1974; 2: 380
   PubMed Web of Science ®Google Scholar
• Traeger A., Hoffman H., Frankie H., Guntner M. Untersuchungen über den Einfluss von Phenobarbital auf Arzneimittelabbauende Enzyme in der Menschlichen Plazenta, auf die Feinstruktur der Chorionzotten und der Verlauf der Serum Bilirubin-konzentration Neugeborener. Z Geburtshilfe Perinatol. 1972; 176: 397
   PubMedGoogle Scholar
• Blanck A., Rane A., Toftgård R., Gustafsson J.-A. Biotransformation of benzo(a)pyrene and 7-ethoxyresorufin and heme-staining proteins in microsomes from human fetal liver and placenta. Biochem. Pharmacol. 1983; 32: 1547
   PubMed Web of Science ®Google Scholar
• Pasanen M., Stenbäck F., Taskinen T., Raunio H., Sivonen P., Hines R., Pelkonen O. Human placental 7-ethoxyresorufinO-deethylase activity: inhibition studies and immunological and molecular biological detection of P450IA1. Cytochrome P-450: Biochemistry and Biophysics, Schuster. Taylor & Francis, London 1989
   Google Scholar
• Nebert D. W., Negishi M., Lang M. A., Hjelmeland L. M., Eisen H. J. TheAh locus, a multiple family necessary for survival in a chemically adverse environment: comparison with the immune system. Adv. Genet. 1982; 21: 1
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Vähäkangas K., Kärki N. T. Genetic and environmental regulation of aryl hydrocarbon hydroxylase in the placenta. Biochemistry, Biophysics and Regulation of Cytochrome P-450, Gustafsson, Carlstedt-Duke, Mode, Rafter. Elsevier/North-Holland, Amsterdam 1980
   Google Scholar
• Pelkonen O., Kärki N. T., Tuimala R. A relationship between cord blood and maternal lymphocytes and term placenta in the induction of aryl hydrocarbon hydroxylase activity. Cancer Lett. 1981; 13: 103
   PubMed Web of Science ®Google Scholar
• Gottlieb K., Manchester D. K. Twin study methodology and variability in xenobiotic placental metabolism. Teratogenesis Carcinog. Mutagen. 1986; 6: 253
   PubMedGoogle Scholar
• Welch R. M., Harrison Y. E., Gommi B. W., Poppers P. J., Finster M., Conney A. H. Stimulatory effect of cigarette smoking on the hydroxylation of 3,4-benzpyrene and theN-demethylation of 3-methyl-4-monomethylaminoazobenzene by enzymes in the human placenta. Clin. Pharmacol. Ther. 1969; 10: 100
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Winker J., Gelboin H. V. Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and non-smoking women. Cancer Res. 1969; 29: 1763
   PubMed Web of Science ®Google Scholar
• Shum S., Jensen N. M., Nebert D. W. The murine Ah locus: in utero toxicity and teratogenesis associated with genetic difference in benzo(a)pyrene metabolism. Teratology 1979; 20: 365
   PubMedGoogle Scholar
• Manchester D. K., Gordon S. K., Golas C. L., Roberts E. A., Okey A. B. Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyrene. Cancer Res. 1987; 47: 4861
   PubMed Web of Science ®Google Scholar
• Négrié C., Triadou N., Michel O., Bouhnik J., Michel R. Oxidative phosphorylation reactions and cholesterol hydroxylation mechanism in human term placental mitochondria. J. Steroid Biochem. 1980; 11: 1135
   Google Scholar
• Graves P. E., Uzgiris V. I., Salhanick H. A. Modification of enzymatic activity and different spectra of cytochrome P450 from various sources by cholesterol side-chain cleavage inhibitors. Steroids 1980; 35: 543
   PubMed Web of Science ®Google Scholar
• John M. E., Simpson E. R., Boggarm V., Waterman M. R. Molecular cloning of steroid hydroxylases. Endocr. Res. 1985; 10: 319
   Web of Science ®Google Scholar
• Pasanen M., Pelkonen O. Purification and immunological characterization of human placental mitochondrial cytochrome P450. J. Steroid Biochem. 1986; 24: 669
   PubMedGoogle Scholar
• Takemori S., Suhara K., Hashimoto S., Gomi T., Katagiri M. Purification of cytochrome P-450 from bovine adrenocortical mitochondria by an “aniline-sepharose” and the properties. Biochem. Biophys. Res. Commun. 1975; 63: 588
   PubMed Web of Science ®Google Scholar
• Usanov S. A., Honkakoski P., Lang M. A., Pasanen M., Pelkonen O., Raunio H. Comparison of the immunochemical properties of human placental and bovine adrenal cholesterol side-chain cleavage enzyme complex. Biochem. Biophys. Acta 1989; 998: 189
   PubMedGoogle Scholar
• Sheets J. J., Moberg P. Q., Vickery L. E. Inhibition of cholesterol conversion to pregenenolone in submitochondrial particles by bovine adrenal cortex and bovine and human placenta by benzidine. J. Steroid Biochem. 1981; 14: 1217
   PubMedGoogle Scholar
• Sheets J. J., Vickery L. E. Effects of aminoglutethimide and its metabolite,N-acetyl-aminoglutethimide, on bovine adrenocortical and human placental cytochromes P450scc. Naunyn-Schmeidebergs Arch. Pharmacol. 1982; 321: 70
   PubMedGoogle Scholar
• Chung B. C., Matteson K. J., Voutilainen R., Mohandas T. K., Liller W. L. Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and the expression in the placenta. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 8963
   Google Scholar
• Thompson E. A. J., Siiteri P. K. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J. Biol. Chem. 1974; 249: 5364
   PubMed Web of Science ®Google Scholar
• Thompson E. A. J., Siiteri P. K. The involvement of human placental microsomal cytochrome P-450 in aromatization. J. Biol. Chem. 1974; 249: 5373
   PubMed Web of Science ®Google Scholar
• Meigs R. A., Moorthy K. B. The support of steroid aromatization by mitochondrial metabolic activities of the human placenta. J. Steroid Biochem. 1984; 20: 883
   PubMedGoogle Scholar
• Moorthy K. B., Meigs R. A. Aromatization of steroids by mitochondrial preparation from human placenta. Biochim. Biophys. Acta 1978; 528: 222
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Smuckler E. A. Subcellular localization of human placental aryl hydrocarbon hydroxylase. Toxicol. Appl. Pharmacol. 1973; 26: 163
   PubMed Web of Science ®Google Scholar
• Pasanen M., Raunio H., Pelkonen O. Freezing affects the activity and subcellular distribution profile of placental xenobiotic- and steroid-metabolizing enzymes. Placenta 1985; 6: 527
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Pasanen M. Effect of heparin on the subcellular distribution of human placental 7-ethoxycoumarinO-deethylase. Biochem. Pharmacol. 1981; 30: 3254
   PubMed Web of Science ®Google Scholar
• Kitawaki J., Inoue S., Tamura T., Yamamoto T., Nogushi T., Osawa Y., Okada H. Increasing aromatase cytochrome P-450 level in human placenta during pregnancy: studied by immunohistochemistry and enzyme-linked immunosorbent assay. Endocrinology 1992; 130: 2751
   PubMed Web of Science ®Google Scholar
• Zachariah P. K., Juchau M. R. Interactions of steroids with human placental cytochrome P-450 in the presence of carbon monoxide. Life Sci. 1975; 16: 1689
   PubMed Web of Science ®Google Scholar
• Zachariah P. K., Lee Q. P., Symms K. G., Juchau M. R. Further studies on the properties of human placental microsomal cytochrome P-450. Biochem. Pharmacol. 1976; 25: 793
   PubMed Web of Science ®Google Scholar
• Kelly W. G., Judd D., Stolee A. Aromatization of delta4-androstene-3,17-dione, 19-hydroxy-delta4-androstene-3,17-dione, and 19-oxo-delta4-androstene-3,17-dione at a common catalytic site in human placenta microsomes. Biochemistry 1977; 16: 140
   PubMed Web of Science ®Google Scholar
• Gibb W., Lavoie J.-C. Substrate specificity of the placental microsomal aromatase. Steroids 1980; 36: 507
   PubMed Web of Science ®Google Scholar
• Symms K. G., Juchau M. R. Stabilization, solubilization, partial purification and some properties of cytochrome P-450 present in CaCl2-precipitated human placental microsomes. Life Sci. 1973; 13: 1221
   Web of Science ®Google Scholar
• Nakajin S., Shinoda M., Hall P. F. Purification to homogeneity of aromatase from human placenta. Biochem. Biophys. Res. Commun. 1986; 134: 701
   Google Scholar
• Kellis J. T., Vickery L. E. Purification and characterization of human placental aromatase cytochrome P-450. J. Biol. Chem. 1987; 262: 4413
   PubMed Web of Science ®Google Scholar
• Evans C. T., Ledesma D. B., Schulz T. Z., Simpson F. R., Mendelson C. R. Isolation and characterization of a complementary DNA specific for human aromatase system cytochrome P-450 mRNA. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 6389
   Google Scholar
• Simpson E. R., Kilgore M. W., Mahendroo M. S., Means G. D., Corbin C. J., Mendelson C. R. Regulation of human aromatase cytochrome-P450 gene expression. J. Steroid Biochem. Mol. Biol. 1992; 43: 923
   PubMedGoogle Scholar
• Juchau M. R., Lee Q. H., Blake P. H. Inverse correlation between aryl hydrocarbon hydroxylase activity and conversion of cholesterol to pregnenolone in human placentas at term. Life Sci. 1972; 11: 949
   Web of Science ®Google Scholar
• Conney D. F., Welch R., Kuntzman R., Chang R., Jacobson M., Munro-Faure A. D., Peck A. W., Bye A., Poland A., Poppers P. J., Finster M., Wolff J. A. Effects of environmental chemicals on the metabolism of drugs, carcinogens, and normal body constituents in man. Ann. N.Y. Acad. Sci. 1971; 179: 155
   PubMed Web of Science ®Google Scholar
• Chao S. T., Juchau M. R. Interactions of endogenous and exogenous estrogenic compounds with human placental microsomal cytochrome P-450 (P-450 hpm). J. Steroid Biochem. 1980; 13: 127
   PubMedGoogle Scholar
• Pasanen M. Human placental aromatase activity: use of a C18 reversed-phase cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and non-smoking mothers in vitro. Biol. Res. Pregn. 1985; 6: 94
   PubMedGoogle Scholar
• Pasanen M., Pelkonen O. Cholesterol side-chain cleavage activity in human placenta and bovine adrenals: a one-step method for separation of pregnenolone formed in vitro. Steroids 1984; 43: 517
   PubMed Web of Science ®Google Scholar
• Kellis J. T. J., Vickery L. E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984; 225: 1032
   PubMed Web of Science ®Google Scholar
• Canick J. A., Ryan K. J. Cytochrome P-450 and the aromatization of 16alpha-hydroxy testosterone and androstenedione by human placental microsomes. Mol. Cell. Endocrinol. 1976; 6: 499
   Google Scholar
• Pasanen M., Pelkonen O. Solubilization and partial purification of human placental cytochromes P-450. Biochem. Biophys. Res. Commun. 1981; 103: 1310
   PubMed Web of Science ®Google Scholar
• Lee Q. P., Zachariah P. K., Juchau M. R. Differential inhibition of androst-4-en-3,17-dione aromatization by carbon monooxide in the presence of estr-4-en-3,17-dione. Steroids 1975; 26: 571
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Namkung M. J., Chao S. T. Monooxygenase induction in the human placenta. Interrelationships among position-specific hydroxylations of 17β-estradiol and benzo(a)pyrene. Drug Metab. Dispos. Biol. Fate Chem. 1982; 10: 220
   PubMed Web of Science ®Google Scholar
• Chao S. T., Omniecinski C. J., Namkung M. J., Nelson S. D., Dvorchik B. H., Juchau M. R. Catechol estrogen formation in placental and fetal tissues of humans, macaques, rats and rabbits. Dev. Pharmacol. Ther. 1981; 2: 1
   PubMedGoogle Scholar
• Bui Q., Weisz J. Identification of microsomal, organic hydroperoxide-dependent catechol estrogen formation: comparison with NADPH-dependent mechanism. Pharmacology 1988; 36: 356
   PubMed Web of Science ®Google Scholar
• Manchester D., Jacoby E. Decreased placental monooxygenase activities associated with birth defects. Teratology 1984; 30: 31
   PubMedGoogle Scholar
• Lambert G. H., Nebert D. W. Genetically mediated induction of drug-metabolizing enzymes associated with congenital defects in the mouse. Teratology 1977; 16: 147
   PubMedGoogle Scholar
• Pelkonen O., Saarni H. Unusual patterns of benzo(a)pyrene metabolites and DNA-benzo(a)pyrene adducts produced by human placental microsomes in vitro. Chem. Biol. Interact. 1980; 30: 287
   PubMed Web of Science ®Google Scholar
• Vaught J. B., Gurtoo H. L., Parker N. B., LeBoeuf R., Doctor G. Effects of smoking on benzo(a)pyrene metabolism by human placental microsomes. Cancer Res. 1979; 39: 3177
   PubMed Web of Science ®Google Scholar
• Wong T. K., Blanton T. E., Hunnicutt C. K., Shore D. L., Shore B. E. R. Dose requirements, assay procedures and tissue specificity for PCB induction of P-450 dependent mono-oxygenase activity in the rat: implications for design of studies measuring in vivo induction of human placental mono-oxygenases. J. Appl. Toxicol. 1987; 7: 81
   PubMedGoogle Scholar
• Wang I. Y., Rasmussen R. E., Creasey R., Crocker T. T. Metabolites of benzo(a)pyrene produced by placental microsomes from cigarette smokers and nonsmokers. Life Sci. 1977; 20: 1265
   PubMed Web of Science ®Google Scholar
• Manchester D. K., Bowman E. D., Parker N. B., Caporaso N. E., Weston A. Determinants of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Cancer Res. 1992; 52: 1499
   PubMed Web of Science ®Google Scholar
• Namkung M. J., Juchau M. R. On the capacity of human placental enzymes to catalyze the formation of diols from benzo(a)pyrene. Toxicol. Appl. Pharmacol. 1980; 55: 253
   PubMed Web of Science ®Google Scholar
• Manchester D. K., Weston A., Choi J.-S., Glenwood E. T., Fennessey P. V., Quintana E., Farmer P. B., Mann D. L., Harris C. C. Detection of benzo(a)pyrene diol epoxide-DNA adducts in human placenta. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 9243
   PubMed Web of Science ®Google Scholar
• Vähäkangas K., Bjelogriick N., Sivonen P., Raunio H., Kärki N., Pelkonen O. The formation of benzo(a)pyrene diolepoxide DNA-adducts in human tissues. Cytochrome P-450: Biochemistry and Biophysics, Schuster. Taylor & Francis, London 1989
   Google Scholar
• Hansen C., Asmussen I., Autrup H. Detection of carcinogen-DNA adducts in human fetal tissues by the32P-postlabeling procedure. Environ. Health Perspect. 1993; 99: 229
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Namkung M. J., Jones A. H., DiGiovanni J. Biotransformation and bioactivation of 7,12-dimethylbenz(a)anthracene in human fetal and placental tissues. Drug Metab. Dispos. Biol. Fate Chem. 1978; 6: 273
   PubMed Web of Science ®Google Scholar
• Jones A. H., Fantel A. G., Kocan R. A., Juchau M. R. Bioactivation of procarcinogens to mutagens in human fetal and placental tissues. Life Sci. 1977; 21: 1831
   PubMed Web of Science ®Google Scholar
• Wiestler D. D., Kleihues P., Rice J. M., Ivankovic S. DNA methylation in maternal, fetal and neonatal rat tissues following perinatal administration of procarbazine. J. Cancer Res. Clin. Oncol. 1984; 108: 56
   PubMed Web of Science ®Google Scholar
• Hsieh L.-L., Hsieh T.-T. Detection of aflatoxin B1-DNA adducts in human placenta and cord blood. Cancer Res. 1993; 53: 1278
   PubMed Web of Science ®Google Scholar
• Ilio C. D., Polidoro G., Arduini A., Mucci A., Federichi G. Glutathione peroxidase, glutathione reductase, glutathioneS-transferase, and g-glutamyl-transpeptidase activities in the human early pregnancy placenta. Biochem. Med. 1983; 29: 143
   PubMedGoogle Scholar
• Pacifici G. M., Rane A. GlutathioneS-transferase in the human placenta at different stages of pregnancy. Drug Metab. Dispos. Biol. Fate Chem. 1981; 9: 472
   PubMed Web of Science ®Google Scholar
• Pacifici G. M., Rane A. Epoxide hydrolase in human placenta at different stages of pregnancy. Dev. Pharmacol. Ther. 1983; 6: 83
   PubMedGoogle Scholar
• Guthenberg C., Mannervik B. GlutathioneS-transferase (transferase pii) from human placenta is identical or closely related to glutathioneS-transferase (transferase pii) from erythrocytes. Biochem. Biophys. Acta 1981; 661: 255
   PubMed Web of Science ®Google Scholar
• Kulkarni A., Ronan P., Radulovic L., Strohm B. GlutathioneS-transferase activity during pregnancy in the mouse: effects of trans-stilbene oxide pretreatment. Biochem. Pharmacol. 1984; 33: 3301
   PubMed Web of Science ®Google Scholar
• Warholm M., Guthenberg C., Mannervik B. Molecular and catalytic properties of glutathioneS-transferase from human liver: an enzyme efficiently conjugating epoxides. Biochemistry 1983; 22: 3610
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J. Molecular genetics of the P-450 superfamily. Pharmacol. Ther. 1990; 45: 1
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J., Crespi C. L., Gelboin H. V. cDNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment. Mutat. Res. 1991; 247: 113
   PubMed Web of Science ®Google Scholar
• De Waziers I., Cugnenc P. H., Yang C. S., Leroux J.-P., Leroux H. B. P. Cytochrome P450 isoforms, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther. 1990; 253: 387
   PubMed Web of Science ®Google Scholar
• Forrester L. M., Henderson C. J., Glancey M. J., Back D. J., Park B. K., Ball S. E., Kitteringham N. R., McLaren A. W., Miles J. S., Skett P., Wolf C. R. Relative expression of cytochrome P450 isoforms in human liver and association with the metabolism of drugs and xenobiotics. Biochem. J. 1992; 281: 359
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Turvy C. G. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 1991; 256: 1189
   PubMed Web of Science ®Google Scholar
• Ketterer B., Meyer D., Lalor E., Johnson P., Guengerich F., Distlerath L., Reilly P., Kadlubar F., Flammang T., Yamazoe Y., Beaune P. A comparison of levels of glutathione transferases, cytochrome P450 and acetyltransferases in human livers. Biochem. Pharmacol. 1991; 41: 635
   PubMedGoogle Scholar
• Morel F., Beaune P. H., Ratanasavanh D., Flinois J.-P., Yang C. S., Guengerich F. P., Guillouzo A. Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur. J. Biochem. 1990; 191: 437
   PubMedGoogle Scholar
• Guengerich F., Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 1991; 4: 391
   PubMed Web of Science ®Google Scholar
• Murray M., Reidy G. F. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 1990; 42: 85
   PubMed Web of Science ®Google Scholar